MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 234 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q1 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,430,000 | -21.3% | 95,181 | -12.4% | 0.41% | -15.2% |
| Q2 2022 | $3,088,000 | -18.5% | 108,695 | +1.2% | 0.49% | -3.2% |
| Q1 2022 | $3,789,000 | -14.0% | 107,426 | +2.1% | 0.50% | -16.9% |
| Q4 2021 | $4,408,000 | +41.5% | 105,195 | +65.7% | 0.60% | +18.4% |
| Q3 2021 | $3,116,000 | +148.7% | 63,489 | +111.4% | 0.51% | +149.3% |
| Q2 2021 | $1,253,000 | +81.1% | 30,031 | +54.8% | 0.20% | +65.3% |
| Q1 2021 | $692,000 | – | 19,405 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $764,690,000 | 24.22% |
| Nekton Capital Ltd. | 1,111,102 | $39,189,000 | 9.66% |
| Pavadi Capital LLC | 133,279 | $4,701,000 | 4.14% |
| Curi Wealth Management, LLC | 420,446 | $14,829,000 | 2.57% |
| Select Equity Group, L.P. | 19,100,056 | $673,659,000 | 2.18% |
| Ownership Capital B.V. | 4,205,521 | $148,329,000 | 1.96% |
| Beck Bode, LLC | 167,969 | $5,924,000 | 1.34% |
| Parkman Healthcare Partners LLC | 77,389 | $2,730,000 | 0.80% |
| STONE RUN CAPITAL, LLC | 55,285 | $1,960,000 | 0.72% |
| Champlain Investment Partners, LLC | 3,582,530 | $126,356,000 | 0.65% |